ABSTRACT
Background: Untreated functional thyroid diseases are a risk factor for maternal and fetal complications during pregnancy. Aim: To determine the frequency of functional or autoimmune thyroid disease in healthy women during the first trimester of pregnancy. Subjets and Methods: healthy pregnant women attending a routine consult during their first trimester of pregnancy were studied. Thyroid stimulating hormone (TSH), total and free thyroxin (T4) anti-thyroid peroxidase (TPO) antibodies and spot urine iodine levels were measured. The reference ranges provided by the Atlanta Georgia Consensus in 2004 were used as normal values. A urine iodine concentration < 150 ug/L was considered low. Results: One hundred women age 30 +/- 5 years with a mean gestational age of 8,8 +/- 1,9 weeks, were studied. The frequencies of subclinical hypothyroidism, clinical hypothyroidism, isolated low thyroxin lecels, high antiTPO antibodies and low urine iodine levels were 19, 2, 3, 13 and 15 percent, respectively. Women with high TSH levels had lower total and free T4 levels. Conclusions: Twenty one percent of this sample of apparently healthy pregnant women had a clinical or subclinical hypothyroidism.
Subject(s)
Humans , Female , Pregnancy , Adolescent , Adult , Middle Aged , Thyroid Diseases/epidemiology , Thyroid Diseases/blood , Pregnancy Complications , Autoantibodies/analysis , Autoimmune Diseases/epidemiology , Thyroid Diseases/immunology , Thyroid Diseases/urine , Hypothyroidism/epidemiology , Pregnancy Trimester, First , Thyrotropin/blood , Iodine/urineABSTRACT
Primary hyperaldosteronism is the most prevalent cause of secondary hypertension. Approximately 10 percentof hypertensive patients may be carriers of this condition. Idiopathic bilateral adrenal hyperplasia (HSBI) and aldosterone producing adenoma (APA) are the most common causes of hyperaldosteronism. To diagnose these conditions, adrenal venous catheterization (CVS) is the test of choice to evaluate functional imagingfindings. The aim of this communication is to demonstrate the usefulness of the CVS in the etiological diagnosis of this condition. We report two patients with primary hyperaldosteronism who were subjected to CVS. A male in whom and abdominal CAT scan showed bilateral adrenal growth, that was severest atthe left side. CVS concluded hyper secretion of aldosterone on the right side, but without suppression of the contralateral gland, corresponding to a bilateral adrenal hyperplasia. A 43 years old male in whom an abdominal CAT scan showed a right adrenal tumor measuring 11 x 5 mm. CVS showed a right lateralization of aldosterone secretion, with suppression of the contralateral gland. The conclusion was the presence of an aldosteronoma, which was excised by laparoscopy with excellent clinical outcome.
Subject(s)
Humans , Male , Middle Aged , Adenoma/diagnosis , Hyperaldosteronism/etiology , Hyperplasia/diagnosis , Adrenal Gland Neoplasms/diagnosis , Aldosterone , Catheterization , Adrenal Glands/pathology , Tomography, X-Ray ComputedABSTRACT
ACTH Independent cushing syndrome, involving both adrenal glands, represents a minority of endogenous hyperadrenocorticisms and is caused by infrequent diseases. ACTH independent macronodular adrenal hyperplasia (AIMAH) is one of them and is caused by aberrant cortical adrenal receptors expression that are able to stimulate cortisol secretion. We report a 62 years old male, presenting with hypertension, weight gain, urinary lithiasis and osteopenia. The diagnosis of Cushing's syndrome was made with a morning cortisol level after 1 mg nocturnal dexamethasone of 8.2 ug/dL. Urinary free 24 hour cortisol levels were normal, circadian rhythm of cortisol was maintained and ACTH was <5 pg/mL. Abdominal magnetic resonance imaging showed bilateral nodular adrenal enlargement. The functional study, looking for abnormal receptors, showed a potent cortisol secretory response after stimulation with vasopressin.
Subject(s)
Humans , Male , Middle Aged , Adrenal Gland Diseases/complications , Adrenal Gland Diseases/etiology , Adrenal Gland Diseases/therapyABSTRACT
Background: Plasmapheresis is a therapeutic alternative for diseases in which a "humoral factor" has pathogenetic relevance. However it is not devoid of adverse effects. Aim: To review the indications, number of procedures, morbidity and clinical evolution of plasmapheresis in critical patients. Patients and Methods: A retrospective and descriptive study in four intensive care units of an University hospital. The severity of patients was evaluated with APACHE II and SOFA scores. Results: Twenty patients were studied. The most common indications of plasmapheresis were thrombotic thrombocytopenic purpura (TTP) in 50% of subjects and small vessel vasculitides in 30%. The number of procedures per patient oscillated between 2 and 14 (mean: 7.1±3.3). The registered adverse effects were hypocalcemia in 50% of patients, hypotension in 42.1%, coagulopathy in 35%, hypokalemia in 29%, rash in 20%, procedure related infections in 18% and fever in 10%. There was a significant decrease of 17±28% in prothrombin time, after the procedures. Seventy five percent of patients had a favorable evolution. Global mortality rate was 15%. All deaths occurred in patients with TTP and were attributed to the progression of the disease. No death was attributed to the procedure. The initial APACHE II and SOFA scores were 12.4±8.4 and 5.3±2.9, respectively. Both scores decreased after the procedure. Among other therapeutic measures, 15% of the patients received immunosuppressant treatment, 27% were dialyzed and 32% were mechanically ventilated. Conclusions: The most common indication of plasmapheresis was TTP. Adverse effects were frequent, however there was no procedure related mortality. The global mortality rate was 15% and all deaths occurred in patients with TTP.
Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Critical Care , Critical Illness/therapy , Plasmapheresis , Purpura, Thrombotic Thrombocytopenic/therapy , APACHE , Chile/epidemiology , Hospitalization , Intensive Care Units , Plasmapheresis/adverse effects , Plasmapheresis/standards , Purpura, Thrombotic Thrombocytopenic/mortality , Retrospective StudiesABSTRACT
Background: Cardiac output can be measured non invasively by transesophageal Doppler. This is an alternative to measure it by thermodilution with a catheter in the pulmonary artery. Aim: To compare both methods of cardiac output measurement. Material and methods: Simultaneous measurement of cardiac output by transesophageal Doppler and thermodilution with a catheter in the pulmonary artery in four male critical patients, aged 60±12 years, hospitalized in a University Hospital. The Bland and Altman method to compare the concordance between two measurements, was used. Results: Forty measurements were performed. The results of both methods had a correlation coefficient of 0.98. According to the Bland and Altman method, the difference between both methods was -0.5 L with a precision of 0.52 L/min (95% confidence interval -1.51 to 0.52 L/min). Considering that a change between two sequential measurements is considered significant when the difference is more than 15%, both measurements agreed in 83% of cases, that there was a change in cardiac output. Conclusions:Transesophageal Doppler is a promising non invasive technique to measure cardiac output in critical care patients. It becomes a valid alternative to the thermodilution technique. This preliminary experience must be confirmed in a larger series.